Reasons to Read

Discover how GLP-1 medications are reshaping US consumer behavior—and what leading retailers must do to respond.

Read this report to discover answers to these and other questions:

• How are GLP-1 users changing what—and how—they buy across grocery, wellness and apparel categories?
• Why are private-label brands uniquely positioned to capture growth from GLP-1 consumer behavior shifts?
• What sizing, inventory and service strategies should apparel retailers adopt as body-size volatility rises?
• How can pharmacies evolve from transactional hubs to loyalty-driving wellness centers for GLP-1 users?
• In what ways can retailers reinvent in-store foodservice to meet demand for protein-rich, portion-controlled meals?

Companies mentioned in this report include: Amazon, ASOS, Conagra Brands, CVS Caremark, Danone, Eli Lilly, Destination XL Group, Gap Inc./Old Navy, Kroger, Marks & Spencer, Nestlé, Novo Nordisk, PepsiCo, Reformation, Target and Walmart.

Data in this report include: GLP-1 market size and growth projections; grocery basket value and item changes among GLP-1 users; consumer lifestyle and dietary shifts; apparel size transitions and preferred services; pharmacy support preferences; and evolving foodservice consumption patterns.